| 1 |
2024 |
Albrecht Stenzinger, Arndt Vogel, Ulrich Lehmann, Angela Lamarca, Paul Hofman, Luigi Terracciano, Nicola Normanno. Molecular profiling in cholangiocarcinoma: A practical guide to next-generation sequencing, Cancer Treatment Reviews. 2024; 122: 102649102649.
https://doi.org/10.1016/j.ctrv.2023.102649 |
| 2 |
2023 |
Hossein Taghizadeh, Theresa Schmalfuss, Agnieszka Maj-Hes, Josef Singer, Gerald W. Prager. Austrian tricentric real-life analysis of molecular profiles of metastatic biliary tract cancer patients, Frontiers in Oncology. 2023; 13: 1143825.
https://doi.org/10.3389/fonc.2023.1143825 |
| 3 |
2023 |
Mireia Mato Prado, Jisce R. Puik, Leandro Castellano, Elena López-Jiménez, Daniel S. K. Liu, Laura L. Meijer, Tessa Y. S. Le Large, Eleanor Rees, Niccola Funel, Shivan Sivakumar, Stephen P. Pereira, Geert Kazemier, Babs M. Zonderhuis, Joris I. Erdmann, Rutger-Jan Swijnenburg, Andrea Frilling, Long R. Jiao, Justin Stebbing, Elisa Giovannetti, Jonathan Krell, Adam E. Frampton. A bile-based microRNA signature for differentiating malignant from benign pancreaticobiliary disease, Experimental Hematology & Oncology. 2023; 12: 101.
https://doi.org/10.1186/s40164-023-00458-3 |
| 4 |
2023 |
Yoshitaro Shindo, Hiroaki Nagano, Masashi Kanai, Shogo Kobayashi, Hiroshi Wada, Daisuke Sakai, Hidetoshi Eguchi, Hideo Baba, Hirofumi Kamachi, Tadatoshi Takayama, Masaki Ueno, Masahiro Takahashi, Yuki Nakagami, Kenichi Yoshimura, Etsuro Hatano, Tatsuya Ioka. Clinical outcomes of second‑line chemotherapy after gemcitabine and cisplatin plus S‑1 treatment for patients with advanced biliary tract cancer in the KHBO1401‑3A study, Oncology Reports. 2023; 49: 41.
https://doi.org/10.3892/or.2023.8478 |
| 5 |
2024 |
Maria Arechederra, Maria Rullán, Daniel Oyón, Matias A. Ávila, Jesús M. Urman, Carmen Berasain. Bile as a liquid biopsy matrix: potential applications and limitations, Exploration of Digestive Diseases. 2024; 5.
https://doi.org/10.37349/edd.2024.00037 |
